SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 43 filers reported holding SUNESIS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $9,000 | -90.9% | 35,114 | -29.0% | 0.00% | – |
| Q3 2018 | $99,000 | -39.6% | 49,450 | -36.1% | 0.00% | – |
| Q2 2018 | $164,000 | +1950.0% | 77,379 | +2438.7% | 0.00% | – |
| Q1 2018 | $8,000 | -90.4% | 3,048 | -86.4% | 0.00% | – |
| Q4 2017 | $83,000 | +277.3% | 22,434 | +91.4% | 0.00% | – |
| Q3 2017 | $22,000 | +46.7% | 11,723 | +177.8% | 0.00% | – |
| Q4 2016 | $15,000 | +87.5% | 4,220 | +133.8% | 0.00% | – |
| Q3 2016 | $8,000 | – | 1,805 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 7,600,000 | $9,234,000 | 7.03% |
| Samsara BioCapital, LLC | 3,750,000 | $4,556,000 | 3.58% |
| CAXTON CORP | 277,245 | $337,000 | 0.31% |
| BVF INC/IL | 2,287,860 | $2,780,000 | 0.31% |
| Eventide Asset Management | 5,965,455 | $7,248,000 | 0.25% |
| Telemetry Investments, L.L.C. | 197,564 | $240,000 | 0.12% |
| NEA Management Company, LLC | 1,298,274 | $1,584,000 | 0.08% |
| RP Management, LLC | 129,517 | $158,000 | 0.08% |
| Palo Alto Investors LP | 1,162,473 | $1,412,000 | 0.06% |
| Fosun International Ltd | 725,000 | $863,000 | 0.06% |